(Q45400758)

14 December 2017

title

Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area (English)

1 reference

14 December 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

1 reference

Kyung Woo Park

1

1 reference

14 December 2017

Joong-Won Park

2

1 reference

14 December 2017

Jun Il Choi

3

1 reference

14 December 2017

Tae Hyun Kim

4

1 reference

14 December 2017

Seong Hoon Kim

5

1 reference

14 December 2017

Hong Suk Park

6

1 reference

14 December 2017

Woo Jin Lee

7

1 reference

14 December 2017

Sang Jae Park

8

1 reference

14 December 2017

Eun Kyung Hong

9

1 reference

14 December 2017

Chang-Min Kim

10

1 reference

14 December 2017

publication date

30 August 2007

1 reference

Journal of Gastroenterology and Hepatology

14 December 2017

published in

1 reference

14 December 2017

volume

23

1 reference

14 December 2017

issue

3

1 reference

14 December 2017

page(s)

467-473

1 reference

Estimating the world cancer burden: Globocan 2000.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Hepatocellular carcinoma: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Updated treatment approach to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Hepatocellular carcinoma: current management and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Clinical presentation and natural course of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05112.X

10.1111/J.1440-1746.2007.05112.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference